2016
DOI: 10.1530/jme-15-0305
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists

Abstract: CRISPR/Cas9 is a recent development in genome editing which is becoming an indispensable element of the genetic toolbox in mice. It provides outstanding possibilities for targeted modification of the genome, and is often extremely efficient. There are currently two main limitations to in ovo genome editing in mice: the first is mosaicism, which is frequent in founder mice. The second is the difficulty to evaluate the advent of off-target mutations, which often imposes to wait for germline transmission to ensur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 120 publications
(96 reference statements)
0
5
0
Order By: Relevance
“…Since its adaptation to mammalian cells 1 , 2 , CRISPR/Cas9 genome editing has become a key element of the genetic toolbox in mice 3 , 4 . The method relies on Streptococcus pyogenes Cas9 (SpCas9), a RNA-guided DNA endonuclease.…”
Section: Introductionmentioning
confidence: 99%
“…Since its adaptation to mammalian cells 1 , 2 , CRISPR/Cas9 genome editing has become a key element of the genetic toolbox in mice 3 , 4 . The method relies on Streptococcus pyogenes Cas9 (SpCas9), a RNA-guided DNA endonuclease.…”
Section: Introductionmentioning
confidence: 99%
“…While identifying novel epistatic interactions with certain disease-associated mutations may be worth the current expense of a long-term mouse breeding program, it is possible that technological advances will make searching for epistatic effects in mice more practical in the near future. For instance, as mouse CRISPR technology becomes more commonly available and efficient ( Markossian and Flamant 2016 ; Tschaharganeh et al 2016 ), it should be possible to delete a gene or introduce a mutation of interest onto existing recombinant inbred strains, like the Collaborative Cross mice. Alternatively, it may not always be necessary to introduce the mutation of interest onto all inbred backgrounds under study.…”
Section: Discussionmentioning
confidence: 99%
“…The CRISPR system was first discovered in Escherichia coli and its role in bacterial resistance to viruses (Doudna & Charpentier, 2014;Jinek et al, 2012). CRISPR/Cas9 can site-specific binding by combining the system with endonuclease Cas9 and utilised in different non-bacterial organisms (Kotwica-Rolinska et al, 2019;Markossian & Flamant, 2016). CRISPR/Cas9 mechanism begins with the site-specific binding of a ~100-nt sequence single guide RNA (sgRNA) to the target sequence of a 5'-NGG-3' protospacer adjacent motif (PAM).…”
Section: Zinc Finger Nucleases (Zfns)mentioning
confidence: 99%